Table 1.

Data sources for validation data related to measures of 5 acute gout domains

Source	N	Inclusion	Treatment groups	Publication
Merck, Sharp & Dohme	150	Onset within 48 hours, 1977 ARA criteria, at least moderate pain	Etoricoxib, indomethacin	(6)
Pfizer	402	Onset within 48 hours, 1977 ARA criteria, at least moderate pain	Celecoxib 50, 400/200, 800/400, indomethacin	(7)
Regeneron	225	Onset within 48 hours, 1977 ARA criteria, at least moderate pain	Indomethacin, rilonacept and indomethacin, rilonacept	Not published (NCT00855920)
Novartis (two replicate studies)	424	Onset of acute flare within 5 days, 1977 ARA criteria, at least 3 flares within prior 12 months, pain at least 50 mm on 100 mm VAS.	Canakinumab 150 mg SQ, triamcinolone 40 mg IM	(2) *
Auckland University of Technology	20	Observational study, acute gout flare at baseline, 1977 ARA criteria	Not applicable	(3)

^*Not published prior to data analyses and presentation, but is now published; the dataset provided to investigators was a 90% random subsample of the main study dataset (n=456)